Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baiyunshan Qixing Pharmaceutical is a prominent Chinese pharmaceutical company specializing in Traditional Chinese Medicine (TCM) and is a core subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings. The company is internationally recognized for its flagship product, Huatuo Zaizao Wan, a specialized TCM formulation used for the treatment and recovery of stroke and cardiovascular disorders. Beyond its cardiovascular portfolio, the company manufactures a wide range of herbal-based treatments for respiratory and pediatric health. Baiyunshan Qixing combines centuries-old herbal traditions with modern manufacturing processes, maintaining multiple GMP-certified production lines. The company plays a significant role in the internationalization of TCM, exporting products to numerous countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baiyunshan Qixing Pharmaceutical.